We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+3.33%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22.8M
AUM Growth
+$681K
Cap. Flow
-$442M
Cap. Flow %
-1,939.41%
Top 10 Hldgs %
14.43%
Holding
3,409
New
162
Increased
850
Reduced
1,040
Closed
145

Top Buys

Rank Stock Value
1
EA icon
Electronic Arts
EA
+$114M
2
CDNS icon
Cadence Design Systems
CDNS
+$112M
3
FTNT icon
Fortinet
FTNT
+$81.7M
4
CMI icon
Cummins
CMI
+$68.3M
5
XLNX
Xilinx Inc
XLNX
+$58.6M

Sector Composition

Rank Sector Weight
1 Technology 15.74%
2 Healthcare 13%
3 Financials 12.4%
4 Industrials 10.58%
5 Consumer Discretionary 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESE icon
1201
ESCO Technologies
ESE
$8.4B
$96 ﹤0.01%
1,174
+157
+15% +$11.5K
MOS icon
1202
The Mosaic Company
MOS
$7.1B
$96 ﹤0.01%
3,853
-36,159
-90% -$883K
CAKE icon
1203
Cheesecake Factory
CAKE
$4.32B
$95 ﹤0.01%
2,195
NRT
1204
North European Oil Royalty Trust
NRT
$79.2M
$95 ﹤0.01%
13,500
SGOL icon
1205
abrdn Physical Gold Shares ETF
SGOL
$6.97B
$95 ﹤0.01%
+7,000
New +$88.3K
CRTO icon
1206
Criteo
CRTO
$1.05B
$94 ﹤0.01%
5,497
-528
-9% -$10.4K
SCHE icon
1207
Schwab Emerging Markets Equity ETF
SCHE
$12.4B
$94 ﹤0.01%
3,608
-1,477
-29% -$38.3K
XPO icon
1208
XPO
XPO
$24.4B
$94 ﹤0.01%
4,736
+3,342
+240% +$68.1K
DLB icon
1209
Dolby
DLB
$4.85B
$93 ﹤0.01%
1,450
+274
+23% +$17.5K
NKTR icon
1210
Nektar Therapeutics
NKTR
$2.41B
$93 ﹤0.01%
176
NJ
1211
DELISTED
NIDEC CP (NIHON KABUSHIKI KAISHA)1 ADS REPTG .25 SH COM STK
NJ
$93 ﹤0.01%
2,728
-1,628
-37% -$56
NLY icon
1212
Annaly Capital Management
NLY
$16.9B
$91 ﹤0.01%
2,532
XBI icon
1213
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$91 ﹤0.01%
1,039
PC
1214
DELISTED
PANASONIC CORP ADR (REP 1 SHR COM STK) (JP)
PC
$90 ﹤0.01%
10,897
+3,832
+54% +$32
AXSM icon
1215
Axsome Therapeutics
AXSM
$12.3B
$89 ﹤0.01%
+3,460
New +$69.4K
EVN
1216
Eaton Vance Municipal Income Trust
EVN
$422M
$89 ﹤0.01%
+7,232
New +$88.3K
FCN icon
1217
FTI Consulting
FCN
$4.88B
$89 ﹤0.01%
1,069
+780
+270% +$64.1K
SCHM icon
1218
Schwab US Mid-Cap ETF
SCHM
$14.6B
$89 ﹤0.01%
4,692
+3
+0.1% +$56
ATRI
1219
DELISTED
Atrion Corp
ATRI
$89 ﹤0.01%
+105
New +$92.8K
PRSP
1220
DELISTED
Perspecta Inc. Common Stock
PRSP
$89 ﹤0.01%
3,825
-1,272
-25% -$28.6K
ROG icon
1221
Rogers Corp
ROG
$2.31B
$88 ﹤0.01%
513
-305
-37% -$49.7K
OKTA icon
1222
Okta
OKTA
$23.9B
$87 ﹤0.01%
710
+210
+42% +$22.8K
IYJ icon
1223
iShares US Industrials ETF
IYJ
$2B
$86 ﹤0.01%
1,100
PBH icon
1224
Prestige Consumer Healthcare
PBH
$2.39B
$86 ﹤0.01%
2,719
-19
-0.7% -$565
NSANY
1225
DELISTED
NISSAN MOTOR CO LTD SPONS ADR
NSANY
$86 ﹤0.01%
6,071
+1,140
+23% +$16

Similar funds

Glenmede Trust's Q2 2019 Portfolio in Review

As of Q2 2019, Glenmede Trust held 3,409 positions worth $22.8M, up 3.1% from $22.1M the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Glenmede Trust withdrew a net $442M in Q2 2019, closing 145 positions and reducing 1,040 holdings. Its most notable exit was Sinclair Inc, an estimated $23.5K position sold in full.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in Dow Inc worth $29.7K.

  • Glenmede Trust's largest Q2 2019 buy was Dow Inc: 602,067 shares worth $29.7K.
  • Glenmede Trust added most to Electronic Arts in Q2 2019, an estimated $114M increase.
  • Glenmede Trust's biggest Q2 2019 reduction was Cognizant, cutting an estimated $93.3M.
  • Glenmede Trust fully exited Sinclair Inc in Q2 2019, selling an estimated $23.5K.
  • Glenmede Trust's ten largest holdings make up 14% of its $22.8M portfolio in Q2 2019.
  • Glenmede Trust opened 162 new positions and closed 145 in Q2 2019.
  • Glenmede Trust's portfolio value rose 3.1% quarter-over-quarter to $22.8M.

Based on Glenmede Trust's 13F filing for Q2 2019, filed 13 Aug 2019.